Analysts Revise Outlooks on Microsoft, Waters, and Ciena
Top Wall Street analysts have revised their outlooks on several prominent companies. According to Benzinga, Freedom Capital Markets has raised its price target for Inspire Medical Systems (NYSE:INSP) from $71 to $97.
The analyst, Keith Hinton, maintained a Buy rating for the stock, which closed at $76.78 on Friday. Another notable revision came from Rosenblatt, which increased Securitize Corp's (NYSE:SECZ) price target from $11 to $13.
Rosenblatt analyst Chris Brendler also maintained a Buy rating for Securitize shares, which closed at $10.86 on Friday. In contrast, Mizuho cut Credo Technology Group Holding's (NASDAQ:CRDO) price target from $290 to $245.
Mizuho analyst Vijay Rakesh maintained an Outperform rating despite the revision. Goldman Sachs has also increased its price target for Waters Corp (NYSE:WAT) from $465 to $515, with analyst Evie Koslosky maintaining a Buy rating.
Cantor Fitzgerald raised Microsoft's (NYSE:MSFT) price target from $522 to $608, and Evercore ISI Group upgraded Ciena Corp (NYSE:CIEN) from In-Line to Outperform, raising its price target from $375 to $550.